The VALID Act would create a risk-based regulatory framework for in vitro diagnostics and laboratory-developed tests. ACLA, whose members include Quest and LabCorp, is reviewing the bill but has objected to earlier drafts.
Original source: https://www.healthcaredive.com/news/lawmakers-reintroduce-diagnostic-regulation-bill-that-split-industry/602486/